Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-Associated Macrophages Promote Metastasis of Oral Squamous Cell Carcinoma via CCL13 Regulated by Stress Granule. | Cancers (Basel) | 2022 | 36291863 | PubTator, text mining | PubMed |
| Visual-Based Spatial Coordinate Dominates Probabilistic Multisensory Inference in Macaque MST-d Disparity Encoding. | Brain Sci | 2022 | 36291320 | PubTator, text mining | PubMed |
| ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle. | Aging (Albany NY) | 2022 | 36287187 | PubTator, text mining | PubMed |
| Coding of latent variables in sensory, parietal, and frontal cortices during closed-loop virtual navigation. | Elife | 2022 | 36282071 | PubTator, text mining | PubMed |
| CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma. | Medicine (Baltimore) | 2022 | 36281171 | PubTator, text mining | PubMed |
| Proteomic Approach for Comparative Analysis of the Spike Protein of SARS-CoV-2 Omicron (B.1.1.529) Variant and Other Pango Lineages. | Proteomes | 2022 | 36278694 | PubTator, text mining | PubMed |
| Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination. | Front Oncol | 2022 | 36263199 | PubTator, text mining | PubMed |
| Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer. | Dis Markers | 2022 | 36263004 | PubTator, text mining | PubMed |
| Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages. | Sci Transl Med | 2022 | 36260692 | PubTator, text mining | PubMed |
| GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis. | Front Endocrinol (Lausanne) | 2022 | 36246907 | PubTator, text mining | PubMed |
| Identification of CD161 expression as a novel prognostic biomarker in breast cancer correlated with immune infiltration. | Front Genet | 2022 | 36246587 | PubTator, text mining | PubMed |
| The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement. | Nat Commun | 2022 | 36241613 | PubTator, text mining | PubMed |
| Emerging Targets in Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 36230766 | PubTator, text mining | PubMed |
| Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 36230752 | PubTator, text mining | PubMed |
| The Immune Contexture of Liposarcoma and Its Clinical Implications. | Cancers (Basel) | 2022 | 36230502 | PubTator, text mining | PubMed |
| Periostin: biology and function in cancer. | Cancer Cell Int | 2022 | 36224629 | PubTator, text mining | PubMed |
| The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases. | Oxid Med Cell Longev | 2022 | 36211819 | PubTator, text mining | PubMed |
| Combinatorial treatments of tamoxifen and SM6Met, an extract from Cyclopia subternata Vogel, are superior to either treatment alone in MCF-7 cells. | Front Pharmacol | 2022 | 36210845 | PubTator, text mining | PubMed |
| Decoding the colorectal cancer ecosystem emphasizes the cooperative role of cancer cells, TAMs and CAFsin tumor progression. | J Transl Med | 2022 | 36209225 | PubTator, text mining | PubMed |
| Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma. | Front Cell Infect Microbiol | 2022 | 36204642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=28